个人简介
教育背景
2004.09–2008.07，泰山医学院，生命科学学院，理学学士
2008.09–2011.06，中国药科大学，生命科学与技术学院，理学硕士
2011.09–2014.06，中国药科大学，生命科学与技术学院，理学博士
工作经历
2015.07-2018.03，天津医科大学，基础医学院，博士后
2014.07- 至今，天津医科大学，病原生物学系，讲师
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
(1) Liu Weiying#*, Sun Fengxian #, Wan Moxin, Jiang Fang, Bo Xiangyu, Lin Laixiang, Tang Hua, Xu Shumei*, β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling, Front Pharmacol, 2018, 8: 969.
(2) Liu Weiying #, Wang Shixing, Sun Qi, Yang Zhen, Liu Min, Tang Hua*, DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer, Int J Cancer, 2018, 142(10): 2068-2079.
(3) Sun Fengxian#, Xu Shumei#*, Jiang Fang, Liu Weiying*, Genomic-driven discovery of an amidinohydrolase involved in the biosynthesis of mediomycin A, Appl Microbiol Biotechnol, 2018, 102(5): 2225-2234.
(4) Hu Yang#, Sun Fengxian#, Liu Weiying*, The heat shock protein 70 gene as a new alternative molecular marker for the taxonomic identification of Streptomyces strains, AMB Express, 20188: 144.
(5) Liu Weiying#, Sun Fengxian, Hu Yang*, Genome Mining-Mediated Discovery of a New Avermipeptin Analogue in Streptomyces actuosus ATCC 25421, ChemistryOpen, 2018, 7(7):558-561.
(6) Zhijie Bai, Qing Liu, Xinsheng Wang, Weiying Liu*,APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis,Neoplasma,2019,66(3):470-480.
京公网安备 11010802027423号